Skip to main content
. 2023 Nov 1;41(1):262–270. doi: 10.1007/s12325-023-02713-9

Table 3.

Measurement of hemodynamic values during electroconvulsive therapy

Group Baseline T0 T1 T2 T3 T4 T5 T6 T7
RR (ms) Group C 865.9 ± 223.5 654.2 ± 144.9* 657.3 ± 114.8* 700.1 ± 126 728.4 ± 151.4 717.4 ± 136.3 727.3 ± 156.6 755.4 ± 133.6 752.2 ± 129.7
Group R 944.7 ± 225.1 849.6 ± 249.3 885.4 ± 213.6 826.5 ± 195.1 805.4 ± 177.7 816.2 ± 141.4 852.1 ± 182.5 852.8 ± 174.9 854.6 ± 150.3
sBP (mmHg) Group C 128.5 ± 16.2 177.1 ± 35* 165.3 ± 33.4 156.1 ± 36 146.5 ± 30.3 140.4 ± 28.8 136.2 ± 25.7 145.3 ± 31.1 136.6 ± 26.4
Group R 117 ± 14.1 129 ± 27.2 140.5 ±  29.2 139.5 ± 30.4 134.1 ± 23.3 132.9 ± 23 130.3 ± 22.8 129.6 ± 21.3 130.5 ± 23
dBP (mmHg) Group C 77.7 ± 11.8 107.1 ± 22.4* 101.3 ± 23.2* 95.1 ± 21.3 88.2 ± 18.3 84.2 ± 19.5 81.9 ± 16 88.4 ± 18.7 84.8 ± 20.2
Group R 73.5 ± 10.6 75.4 ± 19.3 80.6 ± 18.3 81.9 ± 19.9 77.1 ± 13.9 74.6 ± 14 73.8 ± 15.5 77.5 ± 14.3 74 ± 15.7

Data are presented as mean ± standard deviation

Group C patients received IV saline, Group R patients received IV remifentanil (1 µg/kg), T0 immediately after electrical convulsion, T1–T7 1–7 min after electrical stimulus, RR RR interval, sBP systolic arterial pressure, dBP diastolic arterial pressure

*p < 0.05 versus remifentanil group